Lara Sullivan
President and CEO at Pyxis Oncology Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Pyxis Oncology Inc., 3 years.
Pyxis Oncology Inc.
Director · President ,CEO & CMO
Chief executive roles
Pyxis Oncology Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 18, 2023 | Pyxis Oncology Inc. | Open-market sale | −8,541 | $2.10 | $17,936 |
| Sep 14, 2023 | Pyxis Oncology Inc. | Open-market sale | −100 | $2.25 | $225 |
| Sep 13, 2023 | Pyxis Oncology Inc. | Open-market sale | −3,000 | $2.27 | $6,810 |
| Sep 13, 2023 | Pyxis Oncology Inc. | Shares withheld for tax | −184,742 | $2.13 | $393,500 |
| Sep 12, 2023 | Pyxis Oncology Inc. | Open-market sale | −4,917 | $2.25 | $11,063 |
| Sep 11, 2023 | Pyxis Oncology Inc. | Open-market sale | −20,000 | $2.27 | $45,400 |
| Sep 7, 2023 | Pyxis Oncology Inc. | Grant or award | +469,483 | — | — |
| Mar 24, 2023 | Pyxis Oncology Inc. | Grant or award | +703,379 | — | — |
| Jan 3, 2023 | Pyxis Oncology Inc. | Grant or award | +95,684 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.